Mixing Covid jabs increases reports of mild side-effects
Adults are more likely to report mild and moderate side-effects after mixing doses of the AstraZeneca and Pfizer Covid vaccines, a study indicates. Chills, headaches...
Moderna
Pfizer expects Covid vaccine demand for years
Demand for Pfizer’s Covid vaccine could bolster its revenues for years, the US drugs giant has said. Pfizer said it was expecting “durable demand” for...
EU says benefits of all approved vaccines outweigh risks
All four vaccines approved for the EU market have a positive benefit-to-risk ratio, the EU Commission’s Directorate-General for Health and Food Safety (SANTE) stated on...
Covid: France approves AstraZeneca vaccine for over-65s
The French government says older people with pre-existing conditions can now get AstraZeneca’s Covid-19 vaccine, revising its stance on the issue. “People affected by co-morbidities...
Second Covid vaccine set for US approval
A second coronavirus vaccine is nearing emergency approval in the US after it was endorsed by a panel of experts. The head of the Food...
Covid-19: Heightened optimism as AstraZeneca vaccine trial enters critical stage
The government has established a Covid-19 vaccine taskforce that will help develop guidelines on the country’s vaccines distribution plan once they are made available. Speaking...
Covid-19: Oxford University vaccine shows 70% protection
The coronavirus vaccine developed by the University of Oxford stops 70% of people developing Covid symptoms, a large-scale trial show. The Oxford researchers have performed...
WHO sees limited COVID-19 vaccine doses in early 2021
The World Health Organization expects ‘very limited’ COVID-19 vaccine doses available in the first half of 2021. WHO chief scientist Soumya Swaminathan said that she...
Moderna: Renewed hope as another COVID-19 vaccine shows 95% protection
A second US company has developed a Coronavirus Vaccine whose developers say is 94.5% effective. The announcement by drug maker Moderna comes hot on the...